热门资讯> 正文
Ocular Therapeutix GAAP每股收益-0.26美元，差0.04美元，收入1，644万美元，差0.59万美元
2024-08-07 19:15
- Ocular Therapeutix press release (NASDAQ:OCUL): Q2 GAAP EPS of -$0.26 misses by $0.04.
- Revenue of $16.44M (+8.2% Y/Y) beats by $0.59M.
More on Ocular Therapeutix
- Ocular Therapeutix: A Speculative Investment For Risk-Tolerant Investors
- Investor Day Slides
- Ocular Therapeutix, Inc. (OCUL) Investor Day Call Transcript
- Ocular Therapeutix Q2 2024 Earnings Preview
- Ocular Therapeutix jumps as TD Cowen upgrades to Buy and hikes PT
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
